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Abstract The mechanism of Fas antigen-mediated apoptosis is 
at present unclear. We show here that the 100,000 x g superna- 
tant from cell lysates prepared from anti-Fas-stimulated JUR- 
KAT T cells, induces chromatin fragmentation in isolated nuclei 
with concomitant morphological changes typically seen in apopto- 
sis. The formation of this apoptotic nuclei promoting activity 
(ANPA) in JURKAT T cells after Fas antigen ligation was 
blocked by the serine protease inhibitors, TPCK and DCI, and 
by the interleukin 1-18-converting enzyme inhibitor, VAD-FMK. 
In addition, chromatin degradation and morphological changes 
mediated by the ANPA in isolated nuclei were inhibited by 
TPCK, but not by DCI or VAD-FMK. These results suggest hat 
Fas-mediated apoptosis in T cells involves the activation of a 
cascade of proteases. 
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1. Introduction 
The Fas antigen is a cell surface receptor belonging to the 
tumour necrosis factor/nerve growth factor super family [1], 
and is capable of inducing apoptosis in a variety of cell types 
that express the antigen [2,3]. The Fas receptor is a 48 kDa 
transmembrane glycoprotein [4], and its cytoplasmic domain 
contains a region of significant sequence homology with the 
tumor necrosis factor receptor p55 [1,4]. Analysis of mutant 
C-terminus Fas antigen suggested the presence of an inhibitory 
as well as a signal transduction domain in the cytoplasmic 
domain of the Fas antigen [5]. Molecular cloning and sequenc- 
ing of the Fas ligand has revealed striking sequence homology 
to tumour necrosis factor (TN F)~ and TN Ffl [6] suggesting that 
TNF  and Fas may utilize similar signalling mechanisms in 
triggering apoptosis. 
The importance of the Fas antigen and its ligand in modulat- 
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ing T cells in the immune system is underscored by the abnor- 
malities observed in mice homozygous for the lymphoprolifer- 
ation (lpr) [28] and generalized lymphoproliferative disorder 
(gld) loci [7,8]. Because of the mutation in the Fas receptor and 
Fas ligand in lpr and gld, respectively, these mice develop an 
auto-immune disorder with striking similarities to systemic 
lupus erythematosus in human [9]. Recent studies have also 
suggested that the Fas antigen is involved in the generation of 
certain T cell-mediated cytotoxic reactions which lead to Ca 2+- 
independent T cell-mediated killing [10,11]. In spite of the large 
number of reports demonstrating that expression of the Fas 
antigen influences multiple aspects of the immune system, little 
is known about the signalling pathway or mechanism leading 
to Fas-mediated apoptosis. Using a cell-free system [12], we 
show in this report that Fas-mediated apoptosis may involve 
the activation of multiple proteases acting at different levels 
during the apoptotic ascade. 
2. Materials and methods 
2.1. CTwmieals 
All media and serum were from Gibco (Paisley, UK). Anti-Fas (clone 
CH-I1) was obtained from Kamiya Biomedical Company (Thousand 
Oaks, USA). N-tosyl-L-lysine chloromethyl ketone (TPCK) and 3,4- 
dichloroisocoumarin (DCI) were purchased from Calbiochem (Not- 
tingham, UK). Z-Val-Ala-Asp-fluoromethyl ketone (VAD-FMK) was 
from Enzyme System Products (Livermore, USA). 
2.2. Cell culture and preparation of 100,000 x g supernatants 
JURKAT T cells (ATCC, Maryland, U.S.A.) were maintained in 
suspension culture using RPMI 1640 medium supplemented with 10% 
heat-inactivated FCS. The cells (30 × 106 cells/ml) were stimulated with 
20 ng/ml anti-human Fas or left untreated for 60 rain at 37°C in RPMI 
1640 (10% FCS). The cells were washed twice with ice-cold R PMI 1640 
(without FCS) and resuspended (-6 × 106 cells per 10pl) in buffer A (40 
mM fl-glycerophosphate, 50 mM NaC1, 2 mM MgCI=, 5 mM EGTA, 
10 mM HEPES, pH 7.0). After three cycles of freezing and thawing, 
the cell lysates were centrifuged for 30 min at 20,000 x g and the pellets 
discarded. The cell lysates were centrifuged for a further 30 min at 
100,000 × g and the supernatants retained. The protein concentration 
in the supernatants was determined using the method of Lowry et al. 
[13] with BSA as standard. 
2.3. Reconstituted in vitro system 
The cell-free system was essentially that described by Lazebnik et al. 
[12] with the exception that DTT was omited from the assays. Rat 
thymocyte nuclei were prepared as described previously [14] and was 
suspended in buffer B (5 mM MgC12, 2.1 M sucrose, 50 mM Tris, pH 
7.5) at a final concentration of 4 5 x 108 nuclei/ml before used. The 
reaction mixture containing 10 ,ug of the supernatant protein and 
5 / 106 nuclei were diluted to a final volume of 30/~1 with buffer A (see 
above), supplemented with an ATP-regeneration system [12]. Samples 
were incubated at 37°C for the time periods indicated before analysis. 
All rights reserved. 
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2.4. Morphological and DNA analysis 
For chromatin staining, nuclei were incubated with propidium iodide 
(50/~g/ml) on ice for 10 rain before confocal microscopy analysis. To 
examine the nuclear ultrastructure, nuclei were suspended in 0.5% low 
melting agarose at 50°C and immediately pipetted intoplug moulds. 
The agarose plugs were then fixed with 2.2% glutaraldehyde in PBS and 
processed for electron microscopy as previously described [15]. Chro-
matin degradation were analysed as previously reported [16,17] using 
conventional and field inversion gel electrophoresis (FIGE). 
3. Results and discussion 
To further understand the mechanisms of Fas-mediated ap- 
optosis, we have prepared the 100,000 x g supernatant from cell 
lysates derived from anti-Fas stimulated human JURKAT T 
cells. When incubated with isolated rat thymocyte nuclei n a 
modified in vitro system [12], the supernatant induced chroma- 
tin cleavage into high molecular weight (HMW) DNA frag- 
ments ranging from > 700 to < 50 kbp (Fig. la), followed by the 
formation of oligonucleosomal length DNA fragments (Fig. 
I b). These results demonstrated the precedence ofHMW DNA 
cleavage during chromatin degradation, which is in line with 
recent reports on various cell types undergoing apoptosis [18- 
20], including JURKAT cells (Wets et al, manuscript submit- 
ted) [28]. Examination of the supernatant-treated nuclei using 
confocal and electron microscopy showed morphological fea- 
tures typical of apoptosis [21,22], i.e. chromatin abutting to- 
wards the nuclear membrane (45 min) and subsequently frag- 
menting into DNA-containing vesicles (60 rain) (Fig. 2a and 
2b). This in vitro system shares many features with JURKAT 
cells undergoing apoptosis after anti-Fas treatment, including 
(i) tbrmation of HMW DNA fragments, (it) generation of ol- 
igonucleosomal length DNA fragments and (iii) fragmentation 
of nuclei nto DNA-containing vesicles (Wets etal, manuscript 
submitted). The apoptotic nuclei promoting activity (ANPA) 
was present only in the supernatant prepared from anti-Fas- 
treated JURKAT cells, control cell supernatant did not have 
this activity (Fig. 2 and Fig. 4). 
The ANPA was abolished after incubating the supernatant 
from anti-Fas-treated JURKAT cells for 30 min at 60°C, and 
was inactivated by trypsin digestion and acidic pH treatment 
suggesting that proteins are involved. Neither the morphologi- 
cal changes nor the chromatin cleavage in isolated nuclei after 
ANPA treatment required the presence of Ca 2+, which is in line 
with several reports showing that Fas-mediated apoptosis in 
Table 1 
Characterization f ANPA 
Treatment Activity 
Control Yes 
After overnight at room temperature Yes 
Heat inactivation 60°C, 30 rain No 
Trypsin digestion* No 
0.4 M HCI for 5 min No 
Supernatant from cell lysates derived from Fas-treated JURKAT cells 
was subjected to he indicated treatment before incubated with isolated 
thymocyte nuclei. The treated nuclei were then examined for ANPA 
activity morphologically using confocal microscopy and hromatin 
cleavage into oligonucleosomal length DNA fragments by agarose gel 
as described in section 2. 
*The ANPA containing supernatant w s incubated with 60yg/ml tryp- 
sin for 60 min at 37 °C, followed by the addition of 156 ~g/ml soybean 
trypsin inhibitor. Parallel incubation in the absence of trypsin had no 
effect on ANPA-induced chromatin degradation in isolated nuclei. 
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Fig. 1. Time course of the induction of chromatm degradation in iso- 
lated rat thymocyte nuclei by the supernatam (Fas supernatant) pre- 
pared from cell lysate derived from anti-Fas stimulated JURKAT cells. 
(A) HMW DNA fragments. (B) Oligonucleosomal length DNA frag- 
ments. Isolated nuclei (5 x 10 ~') were incubated with the supernatant at 
37°C as described in section 2. 
136 S.C~ Chow et aL/FEBS Letters 364 (1995) 134 138 
control nuclei 
(60 ') 
+ control sup. 
(60 ") 
+ Fas sup. 
(45") 
+ Fas sup. 
(60 ) 
A 
control nuclei (60") + Fas supernatant (45") + Fas supernatant (60") 
B Mag. 15,000x Mag. lO,O00x Mag. lO,O00x 
Fig. 2. Morphological changes in i olated thymocyte nuclei resulting from incubation with the supernatant (Fas supernatant) from anti-Fas treated 
JURKAT cells. (A) Propidium iodide staining of nuclear chromatin in nuclei exposed to ANPA. Bar represents 5 pm. (B) Ultrastructural changes 
in nuclei after incubation with the supernatant containing ANPA. Isolated thymocyte nuclei (5 x 106) were incubated with the supernatant at 37°C, 
and at the time points indicated the reactions were terminated on ice and samples prepared for morphological examinations as described in section 2. 
various cell types was Ca 2+ independent [10,11]. However, the 
removal of Mg 2+ from the cell-free system or the addition of 
Zn 2+ or aurintricarboxylic acid, effectively prevented the 
ANPA-induced chromatin cleavage and morphological 
changes in isolated nuclei (results not shown). This presumably 
was due to inactivation ofconstitutive endonuclease(s) required 
for chromatin degradation i the isolated nuclei. 
The ANPA was detected in the cell lysate prepared from 
JURKAT cells after 45 min of anti-Fas timulation and maxi- 
mal activity was observed within 60 min (Fig. 3). The superna- 
tant containing ANPA was unable to digest ,,1, and plasmid 
DNA (not shown), thus, excluding the involvement ofnuclease 
activity. It had no effect on intact cells (rat thymocytes and 
human JURKAT cells), but readily induced DNA fragmenta- 
tion in nuclei solated from both JURKAT cells and rat liver 
(results not shown). This finding suggests the existence of a 
common target and initiation process leading to nuclear chro- 
matin cleavage in cells undergoing Fas-mediated apoptosis. 
Because proteases have b en implicated in apoptosis in vari- 
ous cell types [19,20,23] and recently shown to directly promote 
chromatin degradation i isolated nuclei [24,25], the possibility 
that the formation of ANPA, as well as its manifestations, 
involved proteolysis was examined. Indeed, our recent studies 
(Weis et al, manuscript submitted) showed that TPCK and DCI 
[26] prevented Fas-mediated apoptosis in JURKAT cells, sug- 
gesting that proteolysis may play an important role in this 
model system. First, to determine whether the formation of 
ANPA involves proteolysis, JURKAT cells were pre-treated 
with TPCK, DCI or the interleukin l-fl-converting enzyme 
(ICE) inhibitor, VAD-FMK [27] for 10 rain prior to anti-Fas 
stimulation. All three protease inhibitors were found to effi- 
ciently blocked chromatin cleavage into HMW and oligonucle- 
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Fig. 3. Time-dependent increase in ANPA in JURKAT cells alter 
anti-Fas stimulation. JURKAT cells (30 × 106/ml) were treated with 
anti-Fas (20 ng/ml) at 37°C. At the time points indicated, an aliquot 
of I ml cell suspension was taken and supernatant prepared as outlined 
in section 2. Equivalent amounts of protein from each supernatant were 
incubated with isolated nuclei for 60 min at 37°C, and the formation 
of oligonucleosomal length DNA fragments analyzed using agarose gel 
electrophoresis. 
osomal length DNA fragments in anti-Fas-treated JURKAT 
cells (result not shown). Thus, Fas-mediated apoptosis in T cells 
appears to involve both serine, and ICE-like protease activities. 
Supernatants prepared from these cells (non-apoptotic) did not 
induce chromatin cleavage into HMW DNA fragments (Fig. 
4a) or oligonucleosomal length DNA fragments (not shown) 
when incubated with thymocyte nuclei. However, the addition 
of supernatant containing ANPA to these assays induced chro- 
matin cleavage, indicating that the potential carry over of pro- 
tease inhibitors in the supernatants from treated cells, which 
might have inhibited endogenous proteases involved in chro- 
matin degradation i isolated nuclei [19,20], was negligible (Fig. 
4a). It can be concluded from these findings that the generation 
of ANPA involves proteolytic activity. 
To examine the possibility that the degradation of chromatin 
in isolated nuclei induced by ANPA involves proteolysis, the 
following approach was undertaken. JURKAT cells were first 
stimulated for 60 min with anti-Fas to generate maximal level 
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of ANPA (Fig. 3), before TPCK, DCI  or VAD-FMK were 
added to the cells which were incubated for a further 15 rain. 
This enabled us to discriminate between the effects of the pro- 
tease inhibitors on the ANPA per se from those on its release 
mechanisms. As expected, JURKAT cells stimulated with anti- 
Fas for 60 min prior to treatment with protease inhibitors were 
undergoing apoptosis with their chromatin being cleaved into 
HMW and oligonucleosomal length DNA fragments (results 
not shown). Supernatants were prepared from these cells and 
their ANPA examined. The supernatant from JURKAT cells 
treated with anti-Fas for 60 rain prior to addition of TPCK, was 
unable to induce chromatin cleavage into HMW DNA frag- 
ments (Fig. 4b) or oligonucleosomal length DNA fragments 
(not shown) when incubated with isolated nuclei, and chroma- 
tin degradation occurred only when supernatant containing 
ANPA was included in the assay (Fig. 4b). In contrast, super- 
natants from cells stimulated with anti-Fas prior to addition of 
DCI  or VAD-FMK,  readily induced chromatin degradation in 
isolated nuclei, suggesting that these two inhibitors had no 
effect on the ANPA per se (Fig, 4b). 
Taken together, our results suggest that the formation of 
ANPA in JURKAT cells after ligation of the Fas antigen in- 
volves the activation of both serine and ICE-like proteases. In 
addition, the manifestation of nuclear chromatin cleavage and 
apoptotic morphology by the ANPA appears to involve prote- 
olysis. Since VAD-FMK had no effect on the ANPA itself, the 
possible proteinase activity associated with the ANPA is likely 
to be different from the ICE-like protease activity in mitotic 
extracts [25] reported earlier. In summary, our studies suggest 
that multiple proteases are activated at different levels during 
an apoptotic ascade in T cells after Fas antigen stimulation. 
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Fig. 4. involvement of proteolysis n the formation of the AN PA and its manifestation i  isolated thymocyte nuclei. (A) Effect of protease inhibitors 
on the formation of ANPA in anti-Fas-treated JURKAT cells. Supernatants ( up.) from JURKAT cells pretreated for 10 min with TPCK (100/aM), 
DCI (100/*M) or VAD-FMK (10 yM), followed by anti-Fas stimulation for 75 min were examined for the presence of ANPA (lanes 3, 4 and 5, 
respectively) by FIGE analysis of chromatin degradation i  nuclei incubated with the supernatants. The same supernatants plus supernatant 
containing ANPA (Fas sup.) were added to nuclei (lanes 6, 7 and 8). (B) Effect of the protease inhibitors on the ANPA per se. Supernatants from 
JURKAT cells stimulated with anti- Fas for 75 min, with TPCK, DC1 or VAD-FMK added during the last 15 min of incubation, were examined 
for the ANPA (lanes 3, 4 and 5) by FIGE analysis of treated nuclei. Since no ANPA was detected in the supernatant from cells treated with anti-Fas 
prior to TPCK (lane 3), supernatant containing ANPA was added to the assay (lane 6). 
